Answers are grounded in this paper and cite their sources.
Burn injuries compromise the structural, vascular, immunological, and barrier functions of the skin, creating a self-sustaining wound environment marked by persistent inflammation, oxidative stress, microvascular dysfunction, extracellular matrix degradation, and impaired cellular regeneration. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as promising cell-free therapeutics because they deliver bioactive microRNAs, messenger RNAs, proteins, lipids, and other regulatory molecules to macrophages, endothelial cells, keratinocytes, and fibroblasts. Through these intercellular signals, MSC-EVs can promote inflammatory resolution, angiogenesis, cytoprotection, re-epithelialization, matrix remodeling, and scar modulation. However, the therapeutic potential of freely administered EVs is constrained by rapid clearance, enzymatic degradation, loss through wound exudate, and insufficient retention within injured tissue. Hydrogels address these limitations by providing hydrated, tissue-conforming matrices that preserve EV integrity, regulate local release, and prolong exposure at the burn site. Natural polymers, including hyaluronic acid, collagen, gelatin, chitosan, and alginate, offer biocompatibility and extracellular matrix-like interactions, whereas synthetic materials such as polyethylene glycol (PEG), poly(vinyl alcohol) (PVA), and polyacrylamide allow more precise control over mechanical behavior, degradation, and molecular transport. Injectable, sprayable, and stimuli-responsive platforms further support conformal administration and pathology-responsive release. The available burn evidence derives mainly from thermal injury models, so this review distinguishes burn-specific findings from supportive evidence in other cutaneous wounds. A central premise of this review is that the regenerative activity of EV–hydrogel systems should not be understood as the additive effect of two independent components. Rather, therapeutic performance emerges from the coordinated interaction between vesicular cargo and hydrogel-governed pharmacokinetics. The hydrogel determines when, where, and for how long intact EVs remain available to recipient cells, while EV cargo directs the cellular programs required for tissue repair. This integrated perspective provides a framework for the rational co-design of EV composition, biomaterial properties, and release behavior. Preconditioning, cargo engineering, hybrid biomaterials, and three-dimensional bioprinting may further strengthen this functional integration. Despite substantial preclinical promise, clinical translation remains limited by EV heterogeneity, inconsistent reporting of EV doses and application schedules, limited evidence that vesicles remain intact after release, sparse data on release kinetics and storage stability, manufacturing variability, insufficient burn-specific evidence, and unresolved safety and regulatory requirements. This review critically examines the biological mechanisms, delivery technologies, engineering strategies, and translational barriers associated with hydrogel-loaded MSC-EVs, and advances an integrated design framework for restoring durable, vascularized, and functionally organized skin after burn injury. It also compiles reported EV doses and regimens, release kinetics, and storage conditions to support standardized reporting and product development.
No takes yet. Share an insight, caveat, or question.
Gangadaran et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: